Sakar Healthcare - Quaterly Results

Sakar Healthcare Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 0 | NSE: SAKAR

13 Aug 2024 Evaluate

The revenue for the June 2024 quarter is pegged at Rs. 411.48 millions, about 5.54% up against Rs. 389.89 millions recorded during the year-ago period.The Net Profit of the company registered a slight decline of -15.13% to Rs. 24.12 millions from Rs. 28.42 millions.OP of the company witnessed a marginal growth to 111.59 millions from 105.48 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202406	202306	% Var	202406	202306	% Var	202403	202303	% Var
Sales	411.48	389.89	5.54	411.48	389.89	5.54	1533.52	1333.59	14.99
Other Income	4.60	15.21	-69.76	4.60	15.21	-69.76	31.77	46.75	-32.04
PBIDT	111.59	105.48	5.79	111.59	105.48	5.79	415.41	378.16	9.85
Interest	13.98	20.77	-32.69	13.98	20.77	-32.69	75.90	59.50	27.56
PBDT	97.61	84.71	15.23	97.61	84.71	15.23	339.51	318.61	6.56
Depreciation	50.58	45.19	11.93	50.58	45.19	11.93	180.50	149.86	20.45
PBT	47.03	39.52	19.00	47.03	39.52	19.00	159.01	168.75	-5.77
TAX	22.91	11.10	106.40	22.91	11.10	106.40	42.29	41.18	2.70
Deferred Tax	22.91	11.10	106.40	22.91	11.10	106.40	42.29	41.18	2.70
PAT	24.12	28.42	-15.13	24.12	28.42	-15.13	116.72	127.57	-8.51
Equity	217.50	190.40	14.23	217.50	190.40	14.23	217.50	190.40	14.23
PBIDTM(%)	27.12	27.05	0.24	27.12	27.05	0.24	27.09	28.36	-4.47